Straits Times Index
3,297.55 -26.98 (-0.81%) S&P 500
5,484.08 +52.48 (+0.97%) Dow
38,808.29 +219.13 (+0.57%) Nasdaq
17,906.11 +217.22 (+1.23%) Bitcoin USD
66,968.16 +357.21 (+0.54%) CMC Crypto 200
1,397.78 +9.62 (+0.69%)
NVO Jun 2024 95.000 call
- GlobeNewswire
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 17 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiat
- Fortune
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
Novo's Danish CEO Lars Fruergaard Jørgensen will face the U.S. Senate in September to defend Wegovy's and Ozempic's eye-watering prices.
- Zacks
Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
Novo Nordisk (NVO) closed the most recent trading day at $142.50, moving +0.01% from the previous trading session.
